10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $111,540 | -70.5% | 2,704 | -60.0% | 0.00% | -76.9% |
Q2 2023 | $377,590 | +100056.5% | 6,762 | +0.1% | 0.01% | +8.3% |
Q1 2023 | $377 | +255.7% | 6,758 | +132.9% | 0.01% | +200.0% |
Q4 2022 | $106 | -100.0% | 2,902 | -85.0% | 0.00% | -55.6% |
Q3 2022 | $551,000 | -30.1% | 19,347 | +11.2% | 0.01% | -50.0% |
Q2 2022 | $788,000 | +35.2% | 17,398 | +127.2% | 0.02% | +200.0% |
Q1 2022 | $583,000 | -3.2% | 7,657 | +89.7% | 0.01% | -40.0% |
Q4 2021 | $602,000 | +58.4% | 4,037 | +54.4% | 0.01% | 0.0% |
Q3 2021 | $380,000 | -86.4% | 2,615 | -81.7% | 0.01% | -86.3% |
Q2 2021 | $2,795,000 | -1.8% | 14,273 | -9.2% | 0.07% | +52.1% |
Q1 2021 | $2,846,000 | +466.9% | 15,725 | +343.5% | 0.05% | +220.0% |
Q4 2020 | $502,000 | +1631.0% | 3,546 | +1408.9% | 0.02% | – |
Q3 2020 | $29,000 | -63.3% | 235 | -73.4% | 0.00% | -100.0% |
Q2 2020 | $79,000 | -80.3% | 883 | -83.2% | 0.00% | -90.9% |
Q4 2019 | $401,000 | +60.4% | 5,263 | +6.3% | 0.03% | +94.1% |
Q3 2019 | $250,000 | – | 4,952 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |